Exelixis | EXEL - PE Price to Earnings


Exelixis reported $602.31 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
Agios Pharmaceuticals USD 3.56 0.68 Sep/2025
Akebia Therapeutics 26.5 0.19 Sep/2023
Amgen USD 25.31 15.82 Dec/2025
AstraZeneca USD 27.29 5.8 Dec/2025
Bayer EUR 5.93 0.68 Sep/2025
BioMarin Pharmaceutical USD 19.24 0.21 Dec/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Eisai JPY 26.63 0.46 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Exelixis USD 602.31 586.25 Dec/2025
Genmab DKK 12.75 0.62 Sep/2025
Glaxosmithkline GBP 11.93 6.46 Sep/2025
Incyte USD 14.84 2.79 Dec/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Merck USD 13.92 5.08 Dec/2025
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 835.47 802.2 Dec/2025
Novartis USD 15.74 0.15 Sep/2025
Pfizer USD 14.48 5.18 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Sanofi EUR 15.75 1.53 Dec/2025
Takeda JPY 235.05 184.95 Dec/2025
Xencor USD 29.92 3.22 Sep/2022